“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...
A genetic analysis found that elevated tyrosine levels may reduce lifespan in men. The findings highlight sex specific ...
The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...
Benign prostatic hyperplasia (BPH) is associated with elevated risks for depression and anxiety, with a causal link to ...
Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.
AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...
A new study is providing a clearer picture of the genetic landscape of major depression, revealing that the disorder may have ...
Genetically decreased vitamin D levels are unlikely to have a large effect on risk of type 1 diabetes, according to results of a Mendelian randomization study published in PLOS Medicine. Although ...
Wave's pivotal trial, Dr. William Abraham is working on another heart failure trial as the new CMO at Cardiac Dimensions.
Epcoritamab, rituximab, and lenalidomide combination is approved for relapsed/refractory follicular lymphoma, marking a first in bispecific antibody second-line treatments. The EPCORE FL-1 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback